Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity.

RUNX1/AML1 is required for the development of definitive hematopoiesis, and its activity is altered by mutations, deletions, and chromosome translocations in human acute leukemia. RUNX1 function can be regulated by post-translational modifications and protein-protein interactions. We show that RUNX1 is arginine-methylated in vivo by the arginine methyltransferase PRMT1, and that PRMT1 serves as a transcriptional coactivator for RUNX1 function. Using mass spectrometry, and a methyl-arginine-specific antibody, we identified two arginine residues (R206 and R210) within the region of RUNX1 that interact with the corepressor SIN3A and are methylated by PRMT1. PRMT1- dependent methylation of RUNX1 at these arginine residues abrogates its association with SIN3A, whereas shRNA against PRMT1 (or use of a methyltransferase inhibitor) enhances this association. We find arginine-methylated RUNX1 on the promoters of two bona fide RUNX1 target genes, CD41 and PU.1 and show that shRNA against PRMT1 or RUNX1 down-regulates their expression. These arginine methylation sites and the dynamic regulation of corepressor binding are lost in the leukemia-associated RUNX1-ETO fusion protein, which likely contributes to its dominant inhibitory activity.

[1]  S. Clarke,et al.  RNA and protein interactions modulated by protein arginine methylation. , 1998, Progress in nucleic acid research and molecular biology.

[2]  R. Roeder,et al.  Ordered Cooperative Functions of PRMT1, p300, and CARM1 in Transcriptional Activation by p53 , 2004, Cell.

[3]  Frank Herrmann,et al.  Dynamics of Human Protein Arginine Methyltransferase 1(PRMT1) in Vivo* , 2005, Journal of Biological Chemistry.

[4]  E. Seto,et al.  A Mechanism of Repression by Acute Myeloid Leukemia-1, the Target of Multiple Chromosomal Translocations in Acute Leukemia* , 2000, The Journal of Biological Chemistry.

[5]  R Grosschedl,et al.  ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRalpha enhancer function. , 1997, Genes & development.

[6]  Kamaleldin E Elagib,et al.  RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation. , 2003, Blood.

[7]  G. Felsenfeld,et al.  Methylation of histone H4 by arginine methyltransferase PRMT1 is essential in vivo for many subsequent histone modifications. , 2005, Genes & development.

[8]  J. Zhang,et al.  The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B. , 1995, Oncogene.

[9]  Xing Zhang,et al.  Structure of the predominant protein arginine methyltransferase PRMT1 and analysis of its binding to substrate peptides. , 2003, Structure.

[10]  S. Jhanwar,et al.  Maintaining the self-renewal and differentiation potential of human CD34+ hematopoietic cells using a single genetic element. , 2003, Blood.

[11]  M. Cleary,et al.  RUNX1 associates with histone deacetylases and SUV39H1 to repress transcription , 2006, Oncogene.

[12]  J. Frampton,et al.  The glycoprotein IIb molecule is expressed on early murine hematopoietic progenitors and regulates their numbers in sites of hematopoiesis. , 2003, Immunity.

[13]  F. Alt,et al.  The CBFβ Subunit Is Essential for CBFα2 (AML1) Function In Vivo , 1996, Cell.

[14]  M. Ohki,et al.  Interaction and functional cooperation of the leukemia‐associated factors AML1 and p300 in myeloid cell differentiation , 1998, The EMBO journal.

[15]  H R Herschman,et al.  PRMT1 Is the Predominant Type I Protein Arginine Methyltransferase in Mammalian Cells* , 2000, The Journal of Biological Chemistry.

[16]  T. Hoshino,et al.  ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Y. Yamauchi,et al.  Human Fibrillarin Forms a Sub-complex with Splicing Factor 2-associated p32, Protein Arginine Methyltransferases, and Tubulins α3 and β1 That Is Independent of Its Association with Preribosomal Ribonucleoprotein Complexes* , 2004, Journal of Biological Chemistry.

[18]  Brian T. Chait,et al.  E Protein Silencing by the Leukemogenic AML1-ETO Fusion Protein , 2004, Science.

[19]  D. Reinberg,et al.  Tips in analyzing antibodies directed against specific histone tail modifications. , 2004, Methods in enzymology.

[20]  S. Minucci,et al.  Aberrant Recruitment of the Nuclear Receptor Corepressor-Histone Deacetylase Complex by the Acute Myeloid Leukemia Fusion Partner ETO , 1998, Molecular and Cellular Biology.

[21]  Mark T Bedford,et al.  Arginine methylation an emerging regulator of protein function. , 2005, Molecular cell.

[22]  N. Speck,et al.  Cooperative binding of Ets-1 and core binding factor to DNA , 1994, Molecular and cellular biology.

[23]  S. Ogawa,et al.  AML1 Is Functionally Regulated through p300-mediated Acetylation on Specific Lysine Residues* , 2004, Journal of Biological Chemistry.

[24]  Z. Paroush,et al.  Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[25]  W. Herr,et al.  Ethidium bromide provides a simple tool for identifying genuine DNA-independent protein associations. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[26]  E. Scott,et al.  Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. , 1994, Science.

[27]  P. Silver,et al.  Arginine methyltransferase affects interactions and recruitment of mRNA processing and export factors. , 2004, Genes & development.

[28]  M. Mann,et al.  Identifying and quantifying in vivo methylation sites by heavy methyl SILAC , 2004, Nature Methods.

[29]  M. Marín‐Padilla,et al.  Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene , 1997, Nature Genetics.

[30]  Wei Zhu,et al.  Arginine Methylation of STAT1 Modulates IFNα/β-Induced Transcription , 2001, Cell.

[31]  D. Littman,et al.  Differential Requirements for Runx Proteins in CD4 Repression and Epigenetic Silencing during T Lymphocyte Development , 2002, Cell.

[32]  J. Downing,et al.  AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis , 1996, Cell.

[33]  N. Hernandez,et al.  A positioned nucleosome on the human U6 promoter allows recruitment of SNAPc by the Oct-1 POU domain. , 2001, Molecular cell.

[34]  Lin-Feng Chen,et al.  A WW domain‐containing Yes‐associated protein (YAP) is a novel transcriptional co‐activator , 1999, The EMBO journal.

[35]  M. Stallcup,et al.  Activation of nuclear receptor coactivator PGC-1α by arginine methylation , 2005 .

[36]  Ya-Li Yao,et al.  Targeted recruitment of a histone H4-specific methyltransferase by the transcription factor YY1. , 2003, Genes & development.

[37]  Y. Okuno,et al.  PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis , 2008, Nature Genetics.

[38]  John W Fathman,et al.  Arginine methylation of NIP45 modulates cytokine gene expression in effector T lymphocytes. , 2004, Molecular cell.

[39]  S. Nimer,et al.  Functional and Physical Interactions between AML1 Proteins and an ETS Protein, MEF: Implications for the Pathogenesis of t(8;21)-Positive Leukemias , 1999, Molecular and Cellular Biology.

[40]  M. Ohki,et al.  Activation of AML1‐mediated transcription by MOZ and inhibition by the MOZ–CBP fusion protein , 2001, The EMBO journal.

[41]  S. Nimer,et al.  Effects of the leukemia-associated AML1-ETO protein on hematopoietic stem and progenitor cells , 2004, Oncogene.

[42]  J. Zhang,et al.  AML1A and AML1B can transactivate the human IL-3 promoter. , 1997, Journal of immunology.

[43]  François-Michel Boisvert,et al.  A Proteomic Analysis of Arginine-methylated Protein Complexes* , 2003, Molecular & Cellular Proteomics.

[44]  S. Orkin,et al.  Expression of CD41 marks the initiation of definitive hematopoiesis in the mouse embryo. , 2003, Blood.

[45]  Brian D. Strahl,et al.  Methylation of histone H4 at arginine 3 occurs in vivo and is mediated by the nuclear receptor coactivator PRMT1 , 2001, Current Biology.

[46]  J. Downing,et al.  Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia. , 2002, Cancer cell.

[47]  D. Tenen,et al.  CCAAT Enhancer-Binding Protein ( C / EBP ) and AML 1 ( CBF a 2 ) Synergistically Activate the Macrophage Colony-Stimulating Factor Receptor Promoter , 1995 .

[48]  C. Allis,et al.  Methylation of Histone H4 at Arginine 3 Facilitating Transcriptional Activation by Nuclear Hormone Receptor , 2001, Science.

[49]  N. Lenny,et al.  The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation , 1995, Molecular and cellular biology.

[50]  K. Tanaka,et al.  The extracellular signal-regulated kinase pathway phosphorylates AML1, an acute myeloid leukemia gene product, and potentially regulates its transactivation ability , 1996, Molecular and cellular biology.

[51]  G. Nucifora,et al.  SUV39H1 interacts with AML1 and abrogates AML1 transactivity. AML1 is methylated in vivo , 2003, Oncogene.